Switzerland
Tuberculosis profile
Population  2012 8 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.017 (0.017–0.018) 0.22 (0.21–0.22)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 0.57 (0.19–1.2) 7.1 (2.3–15)
Incidence  (includes HIV+TB) 0.48 (0.42–0.54) 6 (5.2–6.8)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.09 (0.08–0.11)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 87 (29) Relapse    
Smear-negative 29 (10) Treatment after failure    
Smear-unknown / not done 95 (32) Treatment after default    
Extrapulmonary 84 (28) Other 47 (100)
Other          
Total new 295   Total retreatment 47  
           
Other (history unknown) 121        
Total new and relapse 295   Total cases notified 463  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.4 1.3 1.0
Age < 15 0 11 2
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.2 (0.25–3.5) 13 (3.6–30)
MDR-TB cases among notified pulmonary
TB cases
3 (1–7) 6 (2–14)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 246 (98%) 31 (66%) 373
Laboratory-confirmed MDR-TB cases 3 4 8
Patients started on MDR-TB treatment     8
Financing TB control 2013
National TB programme budget (US$ millions) 3
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data